Condition: Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS) · Sponsor: Nationwide Children's Hospital
The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).
This description comes directly from the study's public registry record.
Mark Hall, MD · 6147223438 · mark.hall@nationwidechildrens.org
Always discuss trial participation with your own doctor first.
| Children's of Alabama | Birmingham, Alabama, United States | Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Recruiting |
| Children's Hospital of Los Angeles | Los Angeles, California, United States | Recruiting |
| Benioff Children's Hospital - Oakland | Oakland, California, United States | Recruiting |
| Children's Hospital of Orange County | Orange, California, United States | Not Yet Recruiting |
| University of California, Davis | Sacramento, California, United States | Recruiting |
| Rady Children's Hospital | San Diego, California, United States | Recruiting |
| Benioff Children's Hospital - Mission Bay | San Francisco, California, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Children's National Medical Center | Washington D.C., District of Columbia, United States | Recruiting |
| Children's Hospital of Atlanta | Atlanta, Georgia, United States | Recruiting |
| Riley Children's Hospital | Indianapolis, Indiana, United States | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05267821